WallStSmart

nVent Electric PLC (NVT)vsWest Pharmaceutical Services Inc (WST)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

nVent Electric PLC generates 27% more annual revenue ($3.89B vs $3.07B). NVT leads profitability with a 18.2% profit margin vs 16.1%. NVT appears more attractively valued with a PEG of 1.57. NVT earns a higher WallStSmart Score of 67/100 (B-).

NVT

Strong Buy

67

out of 100

Grade: B-

Growth: 8.0Profit: 7.0Value: 8.7Quality: 5.0

WST

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.7Quality: 7.3
Piotroski: 5/9Altman Z: 4.91
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NVTUndervalued (+10.8%)

Margin of Safety

+10.8%

Fair Value

$126.36

Current Price

$116.98

$9.38 discount

UndervaluedFair: $126.36Overvalued
WSTSignificantly Overvalued (-256.8%)

Margin of Safety

-256.8%

Fair Value

$68.99

Current Price

$243.35

$174.36 premium

UndervaluedFair: $68.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NVT1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
41.8%10/10

Revenue surging 41.8% year-over-year

WST2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.9110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

Areas to Watch

NVT2 concerns · Avg: 3.0/10
PEG RatioValuation
1.574/10

Expensive relative to growth rate

P/E RatioValuation
46.5x2/10

Premium valuation, high expectations priced in

WST3 concerns · Avg: 3.3/10
P/E RatioValuation
36.1x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
2.1%4/10

2.1% earnings growth

PEG RatioValuation
2.892/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : NVT

The strongest argument for NVT centers on Revenue Growth. Profitability is solid with margins at 18.2% and operating margin at 16.2%. Revenue growth of 41.8% demonstrates continued momentum.

Bull Case : WST

The strongest argument for WST centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 16.1% and operating margin at 21.6%.

Bear Case : NVT

The primary concerns for NVT are PEG Ratio, P/E Ratio. A P/E of 46.5x leaves little room for execution misses.

Bear Case : WST

The primary concerns for WST are P/E Ratio, EPS Growth, PEG Ratio.

Key Dynamics to Monitor

NVT profiles as a growth stock while WST is a mature play — different risk/reward profiles.

NVT carries more volatility with a beta of 1.30 — expect wider price swings.

NVT is growing revenue faster at 41.8% — sustainability is the question.

WST generates stronger free cash flow (175M), providing more financial flexibility.

Bottom Line

NVT scores higher overall (67/100 vs 55/100), backed by strong 18.2% margins and 41.8% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

nVent Electric PLC

INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA

nVent Electric plc designs, manufactures, markets, installs and services electrical connection and protection products in the United States, Canada, Western and Eastern Europe included in the European Union, China, Eastern Europe not included in the European Union, America Latin, Middle East, Southeast Asia, Australia and Japan. The company is headquartered in London, the United Kingdom.

West Pharmaceutical Services Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.

Want to dig deeper into these stocks?